Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
NEPH Nephros Inc
- Stocks
- Healthcare
- NASDAQ: NEPH
Price (delayed)
$2.16
Market cap
$22.9M
P/E Ratio
216
Dividend/share
N/A
EPS
$0.01
Enterprise value
$20.55M
Nephros is a leading water technology company in medical and commercial water purification and pathogen detection, headquartered in the USA. Its diverse team of passionate employees are dedicated to advancing
Highlights
The EPS has soared by 111% from the previous quarter and by 107% YoY
Nephros's net income has soared by 108% from the previous quarter and by 105% YoY
The company's quick ratio rose by 29% YoY but it fell by 9% QoQ
Key stats
What are the main financial stats of NEPH
Market
Valuations
Earnings
Shares outstanding
10.6M
Market cap
$22.9M
Enterprise value
$20.55M
Price to earnings (P/E)
216
Price to book (P/B)
2.65
Price to sales (P/S)
1.61
EV/EBIT
228.31
EV/EBITDA
90.52
EV/Sales
1.45
Revenue
$14.16M
Gross profit
$8.72M
Operating income
$6,000
Net income
$74,000
EBIT
$90,000
EBITDA
$227,000
Free cash flow
-$542,000
Per share
Balance sheet
Liquidity
EPS
$0.01
EPS diluted
$0.01
Free cash flow per share
-$0.05
Book value per share
$0.81
Revenue per share
$1.35
TBVPS
$0.94
Total assets
$11.21M
Total liabilities
$2.63M
Debt
$1.41M
Equity
$8.59M
Working capital
$6.74M
Debt to equity
0.16
Current ratio
5.31
Quick ratio
3.55
Net debt/EBITDA
-10.35
Margins
Efficiency
Dividend
EBITDA margin
1.6%
Gross margin
61.6%
Net margin
0.5%
Operating margin
0%
Return on assets
0.7%
Return on equity
0.9%
Return on invested capital
1.4%
Return on capital employed
0.9%
Return on sales
0.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NEPH stock price
How has the Nephros stock price performed over time
Intraday
0.93%
1 week
13.68%
1 month
14.29%
1 year
-4.85%
YTD
46.94%
QTD
25.58%
Financial performance
How have Nephros's revenue and profit performed over time
Revenue
$14.16M
Gross profit
$8.72M
Operating income
$6,000
Net income
$74,000
Gross margin
61.6%
Net margin
0.5%
Nephros's net income has soared by 108% from the previous quarter and by 105% YoY
The company's net margin has surged by 107% QoQ and by 105% YoY
The company's operating income has surged by 101% QoQ and by 100% YoY
The operating margin has soared by 100% QoQ and by 100% YoY
Price vs fundamentals
How does NEPH's price correlate with its fundamentals
Growth
What is Nephros's growth rate over time
Valuation
What is Nephros stock price valuation
P/E
216
P/B
2.65
P/S
1.61
EV/EBIT
228.31
EV/EBITDA
90.52
EV/Sales
1.45
The EPS has soared by 111% from the previous quarter and by 107% YoY
NEPH's price to book (P/B) is 35% less than its 5-year quarterly average of 4.1 but 10% more than its last 4 quarters average of 2.4
Nephros's equity has increased by 5% QoQ and by 2.7% YoY
The price to sales (P/S) is 60% lower than the 5-year quarterly average of 4.0 but 15% higher than the last 4 quarters average of 1.4
The revenue has grown by 4.5% from the previous quarter
Efficiency
How efficient is Nephros business performance
Nephros's ROIC has soared by 110% from the previous quarter and by 104% YoY
The ROS has soared by 109% from the previous quarter and by 105% YoY
The ROE has soared by 108% from the previous quarter and by 105% YoY
The return on assets has surged by 108% since the previous quarter and by 105% year-on-year
Dividends
What is NEPH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NEPH.
Financial health
How did Nephros financials performed over time
The current ratio has increased by 33% YoY but it has decreased by 24% QoQ
The company's quick ratio rose by 29% YoY but it fell by 9% QoQ
The company's debt is 84% lower than its equity
The debt to equity has declined by 27% year-on-year and by 11% since the previous quarter
The company's debt fell by 23% YoY and by 5% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.